The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP): (601292007-001)
Abstract
These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a quadrivalent human papillomavirus (HPV) vaccine licensed by the U.S. Food and Drug Administration on June 8, 2006. This report summarizes the epidemiology of HPV and associated diseases, describes the licensed HPV vaccine, and provides recommendations for its use for vaccination among females aged 9-26 years in the United States. Genital HPV is the most common sexually transmitted infection in the United States; an estimated 6.2 million persons are newly infected every year. Although the majority of infections cause no clinical symptoms and are self-limited, persistent infection with oncogenic types can cause cervical cancer in women. HPV infection also is the cause of genital warts and is associated with other anogenital cancers. Cervical cancer rates have decreased in the United States because of widespread use of Papanicolaou testing, which can detect precancerous lesions of the cervix before they develop into cancer; nevertheless, during 2007, an estimated 11,100 new cases will be diagnosed and approximately 3,700 women will die from cervical cancer. In certain countries where cervical cancer screening is not routine, cervical cancer is a common cancer in women. The licensed HPV vaccine is composed of the HPV L1 protein, the major capsid protein of HPV. Expression of the L1 protein in yeast using recombinant DNA technology produces noninfectious virus-like particles (VLP) that resemble HPV virions. The quadrivalent HPV vaccine is a mixture of four HPV type-specific VLPs prepared from the L1 proteins of HPV 6, 11, 16, and 18 combined with an aluminum adjuvant. Clinical trials indicate that the vaccine has high efficacy in preventing persistent HPV infection, cervical cancer precursor lesions, vaginal and vulvar cancer precursor lesions, and genital warts caused by HPV types 6, 11, 16, or 18 among females who have not already been infected with the respective HPV type. No evidence exists of protection against disease caused by HPV types with which females are infected at the time of vaccination. However, females infected with one or more vaccine HPV types before vaccination would be protected against disease caused by the other vaccine HPV types. The vaccine is administered by intramuscular injection, and the recommended schedule is a 3-dose series with the second and third doses administered 2 and 6 months after the first dose. The recommended age for vaccination of females is 11-12 years. Vaccine can be administered as young as age 9 years. Catch-up vaccination is recommended for females aged 13--26 years who have not been previously vaccinated. Vaccination is not a substitute for routine cervical cancer screening, and vaccinated females should have cervical cancer screening as recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Kreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0551 · Cited by 2,184
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
(1994) · PsycEXTRA Dataset · doi:10.1037/e546992006-001 · Cited by 1,714
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Cited by
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21871 · Cited by 3,060
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
Bruni, L., Diaz, M., Castellsagué, X., Ferrer, E., Bosch, F. X., & de Sanjosé, S. (2010) · The Journal of Infectious Diseases · doi:10.1086/657321 · Cited by 1,641
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Self-citationJemal, A., Simard, E. P., Dorell, C., Noone, A.-M., Markowitz, L. E., Kohler, B., Eheman, C., Saraiya, M., Bandi, P., Saslow, D., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs491 · Cited by 993
Self-citationRacial/Ethnic Disparities in the Identification of Children With Autism Spectrum Disorders
Mandell, D. S., Wiggins, L. D., Carpenter, L. A., Daniels, J., DiGuiseppi, C., Durkin, M. S., Giarelli, E., Morrier, M. J., Nicholas, J. S., Pinto-Martin, J. A., et al. (2009) · American Journal of Public Health · doi:10.2105/ajph.2007.131243 · Cited by 946
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Self-citationSaslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 791
Self-citationThe Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000193 · Cited by 706
Self-citationRoush, S. W. (2007) · JAMA · doi:10.1001/jama.298.18.2155 · Cited by 633
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018
Kreisel, K. M., Spicknall, I. H., Gargano, J. W., Lewis, F. M. T., Lewis, R. M., Markowitz, L. E., Roberts, H., Johnson, A. S., Song, R., St. Cyr, S. B., et al. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001355 · Cited by 530
Self-citationEvidence-based clinical guidelines for immigrants and refugees
Pottie, K., Greenaway, C., Feightner, J., Welch, V., Swinkels, H., Rashid, M., Narasiah, L., Kirmayer, L. J., Ueffing, E., MacDonald, N. E., et al. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.090313 · Cited by 526
Markowitz, L. E., Hariri, S., Lin, C., Dunne, E. F., Steinau, M., McQuillan, G., & Unger, E. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit192 · Cited by 521
Self-citationTargeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology
Schwartz, A. L., & Ciechanover, A. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.051208.165340 · Cited by 492
Recurrent Respiratory Papillomatosis: A Review
Derkay, C. S., & Wiatrak, B. (2008) · The Laryngoscope · doi:10.1097/mlg.0b013e31816a7135 · Cited by 488
Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
Slade, B. A. (2009) · JAMA · doi:10.1001/jama.2009.1201 · Cited by 470
Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician's recommendation
Rosenthal, S. L., Weiss, T. W., Zimet, G. D., Ma, L., Good, M. B., & Vichnin, M. D. (2011) · Vaccine · doi:10.1016/j.vaccine.2009.12.063 · Cited by 458
Gerend, M. A., & Shepherd, J. E. (2012) · Annals of Behavioral Medicine · doi:10.1007/s12160-012-9366-5 · Cited by 455
Forhan, S. E., Gottlieb, S. L., Sternberg, M. R., Xu, F., Datta, S. D., McQuillan, G. M., Berman, S. M., & Markowitz, L. E. (2009) · Pediatrics · doi:10.1542/peds.2009-0674 · Cited by 427
Self-citationPennington, H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60963-4 · Cited by 417
Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial
Brewer, N. T., Hall, M. E., Malo, T. L., Gilkey, M. B., Quinn, B., & Lathren, C. (2017) · Pediatrics · doi:10.1542/peds.2016-1764 · Cited by 415
Asthma and Allergic Inflammation
Locksley, R. M. (2010) · Cell · doi:10.1016/j.cell.2010.03.004 · Cited by 408
Hariri, S., Unger, E. R., Sternberg, M., Dunne, E. F., Swan, D., Patel, S., & Markowitz, L. E. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir341 · Cited by 380
Self-citationHealth and Economic Implications of HPV Vaccination in the United States
Kim, J. J., & Goldie, S. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0707052 · Cited by 365
Human Papillomavirus Vaccine Introduction – The First Five Years
Markowitz, L. E., Tsu, V., Deeks, S. L., Cubie, H., Wang, S. A., Vicari, A. S., & Brotherton, J. M. L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.039 · Cited by 364
Self-citationSurveillance of Vaccination Coverage Among Adult Populations —United States, 2018
Lu, P.-J., Hung, M.-C., Srivastav, A., Grohskopf, L. A., Kobayashi, M., Harris, A. M., Dooling, K. L., Markowitz, L. E., Rodriguez-Lainz, A., & Williams, W. W. (2021) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7003a1 · Cited by 346
Self-citationPersistence of human papillomavirus infection: keys to malignant progression
Bodily, J., & Laimins, L. A. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.10.002 · Cited by 339
Parents' health beliefs and HPV vaccination of their adolescent daughters
Reiter, P. L., Brewer, N. T., Gottlieb, S. L., McRee, A.-L., & Smith, J. S. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.05.024 · Cited by 319
Human papillomavirus infection: Epidemiology and pathophysiology
Steben, M., & Duarte-Franco, E. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.07.067 · Cited by 307
Dempsey, A. F., Pyrznawoski, J., Lockhart, S., Barnard, J., Campagna, E. J., Garrett, K., Fisher, A., Dickinson, L. M., & O’Leary, S. T. (2018) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2018.0016 · Cited by 288
Gerend, M. A., & Magloire, Z. F. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2007.08.022 · Cited by 283
Ylitalo, K. R., Lee, H., & Mehta, N. K. (2013) · American Journal of Public Health · doi:10.2105/ajph.2011.300600 · Cited by 283
Formaldehyde Exposure and Asthma in Children: A Systematic Review
McGwin, G., Lienert, J., & Kennedy, J. I. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901143 · Cited by 281
Nanoparticles for nasal vaccination
Csaba, N., Garcia-Fuentes, M., & Alonso, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.005 · Cited by 277
Parents' Medication Administration Errors: Role of Dosing Instruments and Health Literacy
Yin, H. S., Mendelsohn, A. L., Wolf, M. S., Parker, R. M., Fierman, A., van Schaick, L., Bazan, I. S., Kline, M. D., & Dreyer, B. P. (2010) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.269 · Cited by 273
Caskey, R., Lindau, S. T., & Alexander, G. C. (2009) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2009.04.021 · Cited by 270
The role of HPV in head and neck cancer and review of the HPV vaccine
D'Souza, G., & Dempsey, A. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.001 · Cited by 267
Underdiagnosis and Referral Bias of Autism in Ethnic Minorities
Begeer, S., Bouk, S. E., Boussaid, W., Terwogt, M. M., & Koot, H. M. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0611-5 · Cited by 264
Hirth, J. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1512453 · Cited by 256
Cervical cancer in India and HPV vaccination
Kaarthigeyan, K. (2012) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.96961 · Cited by 254
Brewer, N. T., Gottlieb, S. L., Reiter, P. L., McRee, A.-L., Liddon, N., Markowitz, L., & Smith, J. S. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181f12dbf · Cited by 254
Self-citationRacism and Health II: A Needed Research Agenda for Effective Interventions
Williams, D. R., & Mohammed, S. A. (2013) · American Behavioral Scientist · doi:10.1177/0002764213487341 · Cited by 189
Over the counter but no longer under the radar - pediatric cough and cold medications
Sharfstein, J. M., North, M., & Serwint, J. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmp0707400 · Cited by 158
Rashid, S., Labani, S., & Das, B. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166713 · Cited by 157
Bodson, J., Wilson, A., Warner, E. L., & Kepka, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0183725 · Cited by 105
Integrating clinical, community, and policy perspectives on human papillomavirus vaccination
Fernández, M. E., Allen, J. D., Mistry, R., & Kahn, J. A. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103609 · Cited by 97
Managing Asthma with Mobile Phones: A Feasibility Study
Holtz, B., & Whitten, P. (2009) · Telemedicine and e-Health · doi:10.1089/tmj.2009.0048 · Cited by 78
Dextromethorphan abuse: Clinical effects and management
Romanelli, F., & Smith, K. M. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.08091 · Cited by 77
Increased Risk for School Violence‐Related Behaviors Among Adolescents With Insufficient Sleep
Hildenbrand, A. K., Daly, B. P., Nicholls, E., Brooks‐Holliday, S., & Kloss, J. D. (2013) · Journal of School Health · doi:10.1111/josh.12044 · Cited by 63
Paediatricians' attitudes and practices towards HPV vaccination
Ishibashi, K. L., Koopmans, J., Curlin, F. A., Alexander, K. A., & Ross, L. F. (2008) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00958.x · Cited by 50
The Effectiveness of Narrative Therapy With Young People With Autism
Cashin, A., Browne, G., Bradbury, J., & Mulder, A. (2013) · Journal of Child and Adolescent Psychiatric Nursing · doi:10.1111/jcap.12020 · Cited by 49
Coalition, F. T. L. A. C. R., Mueller, N. T., Noone, A.-M., Luta, G., Wallington, S. F., Huerta, E. E., & Mandelblatt, J. S. (2012) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-011-9501-6 · Cited by 21
Li, F., & Cui, J. (2015) · Medical Oncology · doi:10.1007/s12032-015-0649-0 · Cited by 18
Metadata
- Authors
- Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R.
- Venue
- PsycEXTRA Dataset
- Published
- 2007
- Volume
- 56
- Issue
- RR-2
- Pages
- 1-24
- OpenAlex
- W2892002136
- Cited by
- 1,882
- References
- 89
- Type
- dataset
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.